A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of ...

ATED Therapeutics Ltd. announced a new diagnostic test for Parkinson's Disease, developed at Hebrew University in Jerusalem, Israel. The test measures transfer RNA fragments (tRF's) from nucleated red ...

Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its ...

A novel RNA-based blood test enables early, accurate, and affordable detection of Parkinson’s disease before symptoms appear.

A RNA blood test developed by researchers can detect Parkinson’s disease years before symptoms appear by measuring specific ...

Researchers have developed a simple and cost-effective blood test capable of detecting Parkinson's disease long before ...

Researchers have developed a simple and cost-effective blood test capable of detecting Parkinson's disease long before symptoms emerge, comparing the ...

Researchers have developed a simple and cost-effective blood test capable of detecting Parkinson’s disease long before symptoms emerge, comparing the current state of diagnosing neurodegenerative ...

Recently, the research teams led by Professors Yu Tao and Feng Yugong from The Affiliated Hospital of Qingdao University ...

The new test can be used to identify pre-symptomatic patients with Parkinson's disease and can measure progression of the disease. ATED Therapeutics Ltd. announced a new diagnostic test for Parkinson' ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.